Drug intelligence / Profile preview

Kangxinning

Development stage
Unknown
Lead developer
Inner Mongolia Autonomous Region Pharmaceutical Industry Research Institute
Modality
Small Molecules
Administration
Oral
01

Overview

Kangxinning is a Chinese patent medicine developed by the Inner Mongolia Autonomous Region Pharmaceutical Industry Research Institute Co., Ltd., primarily indicated for the treatment of coronary heart disease and angina pectoris. Formulated typically as a capsule, it contains a combination of Traditional Chinese Medicine (TCM) extracts, including *Salvia miltiorrhiza* (Danshen), *Panax notoginseng* (Sanqi), *Dalbergia odorifera* (Jiangxiang), and *Borneolum syntheticum* (Bingpian). The drug exerts its therapeutic effects by promoting blood circulation, resolving blood stasis, and dilating coronary arteries, which improves myocardial blood supply and reduces oxygen consumption. It is clinically used to relieve symptoms such as chest pain, palpitations, and shortness of breath associated with cardiovascular stasis.

Brand names
Kangxinning
Other names
Kangxinning CapsuleKangxinning Jiaonang

Beyond the preview

Go deeper on Kangxinning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangxinning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call